Patents by Inventor Thomas Felzmann

Thomas Felzmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for producing dendritic cells with an siRNA that interferes with MAPKAPK2 expression
    Patent number: 9303246
    Abstract: The present invention relates to a method for producing dendritic cells and their use in medicaments by genetic engineering aimed at functionally improving their therapeutic efficacy in the treatment of cancer, microbial infections, allergies, auto-immune diseases or organ and stem cell transplant rejection.
    Type: Grant
    Filed: December 12, 2008
    Date of Patent: April 5, 2016
    Assignee: TRIMED BIOTECH GMBH
    Inventors: Thomas Felzmann, Alexander Michael Dohnal
  • Use of dendritic cells (DCs) expressing interleukin 12 (IL-12)
    Patent number: 7867488
    Abstract: The present invention discloses the use of active dendritic cells (DCs) releasing interleukin 12 (IL-12) which are loaded with an antigen against a specific pathogen or a specific tumor and, due to the treatment with lipopolysaccharide (LPS) and interferon-gamma (IFN-?), release IL-12, for the preparation of a medicament for treating a patient having an infection with said specific pathogen or for treating a patient having said specific tumor.
    Type: Grant
    Filed: August 29, 2003
    Date of Patent: January 11, 2011
    Assignee: Forschungsinstitut fur Krebskranke Kinder
    Inventor: Thomas Felzmann
  • Method for Producing Dendritic Cells
    Publication number: 20100285072
    Abstract: The present invention relates to a method for producing dendritic cells and their use in medicaments by genetic engineering aimed at functionally improving their therapeutic efficacy in the treatment of cancer, microbial infections, allergies, auto-immune diseases or organ and stem cell transplant rejection.
    Type: Application
    Filed: December 12, 2008
    Publication date: November 11, 2010
    Applicant: TRIMED BIOTECH GMBH
    Inventors: Thomas Felzmann, Alexander Michael Dohnal
  • Use of dendritic cells (dcs) expressing interleukin 12 (il-12)
    Publication number: 20060177420
    Abstract: The present invention discloses the use of active dendritic cells (DCs) releasing interleukin 12 (IL-12) which are loaded with an antigen against a specific pathogen or a specific tumor and, due to the treatment with lipopolysaccharide (LPS) and interferon-gamma (IFN-?), release IL-12, for the preparation of a medicament for treating a patient having an infection with said specific pathogen or for treating a patient having said specific tumor.
    Type: Application
    Filed: August 29, 2003
    Publication date: August 10, 2006
    Applicant: FORSCHUNGSINSTITUT FUR KREBSKRANKE KINDER
    Inventor: Thomas Felzmann